Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial / Yves Dion en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 31-39 Título : Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial Tipo de documento: texto impreso Autores: Yves Dion, Autor ; Lawrence Annable, Autor ; Paul Sandor, Autor Fecha de publicación: 2023 Artículo en la página: pp. 31-39 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Discinesia inducida por fármacos, Examen neurológico, Risperidona, Síndrome de Tourette. Resumen: A double-blind, placebo-controlled trial was performed to determine the efficacy and tolerability of 8 weeks of treatment with risperidone in the management of 48 adolescent and adult patients with Tourette syndrome. Twenty-four patients were randomly assigned to treatment with risperidone in doses of 0.5 to 6.0 mg/day, and 24 were assigned to placebo. Link: ./index.php?lvl=notice_display&id=31091 [artículo] Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial [texto impreso] / Yves Dion, Autor ; Lawrence Annable, Autor ; Paul Sandor, Autor . - 2023 . - pp. 31-39. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 31-39 Palabras clave: Discinesia inducida por fármacos, Examen neurológico, Risperidona, Síndrome de Tourette. Resumen: A double-blind, placebo-controlled trial was performed to determine the efficacy and tolerability of 8 weeks of treatment with risperidone in the management of 48 adolescent and adult patients with Tourette syndrome. Twenty-four patients were randomly assigned to treatment with risperidone in doses of 0.5 to 6.0 mg/day, and 24 were assigned to placebo. Link: ./index.php?lvl=notice_display&id=31091

---

1 (1 - 1 / 1)